Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript
Hi, my name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome the CEO of Alnylam, John Maraganore. John, thanks for joining us today. We're going to do a fireside chat. Got a lot of questions, but for anyone who's tuned in and listening, if you have questions, you can send them through the WSW Chatbox, and I'll try to ask those as we go through the fireside chat.
Questions & Answers
So maybe to start off, John, if you can give us an intro to Alnylam for those who might not be familiar with the story.
Yes. Well, Maury, thanks, first of all, thanks for having me here today, and great to be here. I hope everybody is both safe and well. Alnylam is the leading RNAi therapeutics company. We've been pioneering RNAi
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
